The distinction rests on a single question: does the line appear when the face moves, or is it there when the face is at rest? Dynamic lines produced by muscle movement are addressed with botulinum toxin treatment, while lost volume and static lines are addressed with filler. In most plans the two work alongside each other.
Dynamic lines or lost volume? The distinction that decides
Lines on the face do not all form for the same reason, and the right treatment follows the reason. Broadly, two separate mechanisms are at work.
The first is movement. Frowning, smiling or raising the brows folds the skin, and over time the fold leaves a mark. These are dynamic lines, produced by muscle activity, so the answer targets the activity.
The second is volume. With age the fat pads and supporting tissues beneath the skin reduce, and certain areas of the face develop hollowing, shadowing and lines that remain visible even at rest. These are static lines, and their source is not movement but the volume that has gone.
Getting this distinction right resolves the whole comparison. A treatment aimed at movement does not replace lost volume, and a treatment that restores volume does not quiet muscle activity. Substituting one for the other is the most frequent reason a result falls short of what was expected.
What botulinum toxin treatment does, and what it cannot do
The treatment widely referred to by a brand name is properly called botulinum toxin treatment. Botulinum toxin is a prescription medicine, administered only by a physician following medical assessment, and this content is not product promotion.
The working principle is a temporary reduction in the activity of the targeted muscle. When the muscle contracts less, the skin above it folds less, and the appearance of lines produced by expression softens. The change originates not in the skin itself but in the movement beneath it.
The effect is not immediate, though the wait is short. It can begin between the first and third day after treatment, and it generally reaches its clearest point at one to two weeks.
There is also a use for the treatment that is not aesthetic at all. Applied to the masseter, the chewing muscle, it is considered for reducing the symptoms of teeth clenching and grinding. Relief in this setting is usually described at two to three weeks, and the process is planned alongside dental assessment and other options such as a night guard. Because the effect is temporary, this is an approach to managing the problem rather than ending it.
Softening the contour of a wide lower face is also discussed under this heading, where the width comes from muscle volume. There is a firm boundary here though: where the width comes from bone structure, the treatment has no effect. Only medical examination establishes that distinction, and predicting a result before examination is not possible.
What fillers do, and what they cannot do
Hyaluronic acid fillers place the cross-linked gel form of a molecule that occurs naturally in the body into or beneath the skin. The purpose is to restore volume, define contour and reduce the appearance of lines.
What fillers answer is depletion rather than movement. Lost support across the cheekbone, hollowing at the temple, a jawline that has lost its boundary or a line that stays put when the face is at rest all belong to this heading.
One important safety property sets hyaluronic acid apart from other filler materials: where necessary it can be dissolved with the enzyme hyaluronidase. That means an unwanted result or a complication can be acted on, and it is among the main reasons uncrosslinked alternatives that cannot be reversed are not preferred.
What filler cannot do is quiet muscle movement. Placing filler into a line that comes purely from movement does not meet the expectation, and as the area is filled further the natural appearance can suffer as well.
Side by side: mechanism, onset, longevity
Reading the same five criteria separately for each option keeps the comparison from turning into a ranking.
Botulinum toxin treatment
- Mechanism: temporarily reduces the activity of the targeted muscle so the skin folds less. It adds no volume.
- Onset: can begin between the first and third day and generally reaches its clearest point at 1 to 2 weeks.
- Longevity: the effect is temporary; in masseter treatment the reported duration is 3 to 4 months, with any repeat set by medical assessment.
- Recovery: no recovery period is needed; temporary redness at the injection points and occasionally small bruises can occur.
- Who it suits: people with dynamic lines from expression, with clenching symptoms, or with lower face width arising from muscle volume.
Hyaluronic acid filler
- Mechanism: restores volume and defines contour; it does not interfere with muscle movement.
- Onset: the change is visible straight away, but the final appearance settles once swelling has gone down.
- Longevity: varies with area and product; the general range is 6 to 18 months. Mobile areas metabolise faster.
- Recovery: bruising and swelling settle within days to two weeks; assessment is not made before that point.
- Who it suits: people with volume loss, contour irregularity and static lines that remain visible at rest.
Most plans discuss the two together, because most faces carry both components at once. In the forehead, movement from expression and a line that has already deepened can be present side by side; the movement can be addressed with one treatment and the remaining mark with forehead filler. In the same way, masseter treatment aimed at muscle volume and contour work along the jawline can belong to a single plan. The order and the timing are set by the physician, and carrying both out in one session is not a requirement.
Which line gets which treatment?
Looking area by area makes the distinction more concrete.
Between the brows, across the forehead and around the eyes, appearing with movement. The source is muscle activity, so botulinum toxin treatment is considered.
Marks that remain when the face is relaxed. Reducing movement alone falls short here, and filler is assessed.
Support that has gone from the cheekbone, cheek and temple. The subject here is volume rather than a line, and filler answers it.
A picture connected to the size of the chewing muscle. Where the width comes from bone structure the treatment has no effect.
The first thing done at examination follows from this: the face is studied both in movement and at rest. Two lines in the same area can come from different sources, and it is that study which sets the right plan.
Onset and longevity: the schedule
The two treatments differ in when they start and in how long they hold.
Botulinum toxin: day 1 to day 3
The window in which the effect can begin. The final appearance has not settled at this stage.
Botulinum toxin: 1 to 2 weeks
The point at which the effect is clearest. Assessment and any adjustment are made at this stage.
Masseter: 8 to 12 weeks
When the contour change tied to muscle volume shows most clearly. This side of the treatment runs on a longer schedule.
Filler: first days to 2 weeks
The period in which bruising and swelling subside. The final appearance is assessed at the end of it.
Longevity: measured in months
In masseter treatment the reported duration is 3 to 4 months. For filler the general range is 6 to 18 months and varies by area.
With filler, longevity differs markedly from one area to another. In the lip, the most mobile area, the range is generally 6 to 12 months; in less mobile areas such as the cheek and cheekbone, 12 to 18 months and beyond is reported. For the forehead, temple and under-eye areas, ranges of 9 to 12 months and beyond are cited. These are averages, and they shift with the product, the person and the technique.
Risks and who each is not suitable for
The risk profiles differ, and both deserve to be set out.
Clinical studies report low rates of side effects with botulinum toxin treatment. In masseter treatment a temporary reduction in chewing strength and a change in chewing pattern can occur, and these settle over months. The treatment is not carried out during pregnancy or while breastfeeding. It is not carried out in neuromuscular conditions such as myasthenia gravis, where there is infection at the treatment site, or in cases of known allergy.
With fillers the most frequent side effects are bruising and swelling, which settle within days to two weeks. Less frequently, nodule formation, migration of the product and delayed inflammatory reaction are reported, and these require medical follow-up.
The most serious though rare complication is vascular occlusion, where product enters a vessel. It can lead to skin necrosis and, very rarely in the area around the eye and the nose, to loss of vision. The risk is reduced through anatomical knowledge, use of a cannula and slow injection at low pressure, and it requires an emergency hyaluronidase protocol. For that reason filler has to be carried out in a clinical setting by physicians able to manage this complication.
The forehead deserves separate mention under this heading; it carries a dense vascular network, and cannula technique together with experience is decisive there. Fillers are not advised during pregnancy or while breastfeeding, and they are not carried out, or are postponed, where there is active infection, an active cold sore at the site, or a known allergy.
Botulinum toxin or filler: how the decision becomes clear
The decision comes down to three questions. Does the line appear with movement? Is there volume loss in the area? And is what troubles the person a line, or the general shadowing of the face?
When the three are taken together at examination, the plan usually turns out to be a sequence rather than a single treatment. Which side is addressed first, and whether both are carried out in one session, is a medical decision.
Since 2019 the most common misdirection we have observed in the clinic is the assumption that the two are alternatives. In most faces the question is not which one, but which one first and how much. That is why a consultation begins with a description of what is bothering the person rather than with the name of a treatment.
Frequently asked questions
Which wrinkles need botulinum toxin and which need filler?
Dynamic lines that appear with expression are addressed with botulinum toxin treatment, while static lines visible at rest and areas of volume loss are addressed with filler. The distinction is made at examination, with the face studied both in movement and at rest.
Can botulinum toxin and filler be combined?
Most plans discuss the two together, because most faces carry both a movement component and a volume component at once. The order and timing are set by the physician, and carrying both out in one session is not a requirement.
How soon does botulinum toxin treatment work?
The effect can begin between the first and third day after treatment and generally reaches its clearest point at 1 to 2 weeks. Assessment and any adjustment are made at that stage.
How long does botulinum toxin last?
The effect is temporary. In masseter treatment the reported duration is 3 to 4 months, and with regular repeats a longer duration is reported in some people. Any repeat plan follows medical assessment.
How long do fillers last?
It varies with the area and the product, with a general range of 6 to 18 months. Mobile areas such as the lip are generally 6 to 12 months, while less mobile areas such as the cheek and cheekbone are reported at 12 to 18 months and beyond. Forehead, temple and under-eye ranges of 9 to 12 months and beyond are cited.
Does treatment for teeth grinding solve the problem?
The effect is temporary, so this is an approach to managing the problem rather than ending it. In masseter treatment relief is usually described at 2 to 3 weeks, and the process is planned alongside dental assessment and other options such as a night guard.
What is the most serious risk with filler?
The rare but most serious complication is vascular occlusion, where product enters a vessel; it can lead to skin necrosis and very rarely to loss of vision around the eye and nose. It requires an emergency hyaluronidase protocol, so filler should be carried out in a clinical setting by physicians able to manage it.
Who should not have these treatments?
Botulinum toxin treatment is not carried out during pregnancy or breastfeeding, in neuromuscular conditions such as myasthenia gravis, where there is infection at the site, or in cases of known allergy. Fillers are not advised during pregnancy or breastfeeding and are not carried out, or are postponed, where there is active infection, an active cold sore or a known allergy.
This content is provided for general information only and does not constitute medical advice. Botulinum toxin is a prescription medicine, administered only by a physician following medical assessment, and this content is not product promotion. The effect is temporary; in masseter treatment the reported duration is 3 to 4 months, the effect can begin between the first and third day, and it generally becomes clear at 1 to 2 weeks. Where lower face width comes from bone structure rather than muscle volume, the treatment has no effect. It is not carried out during pregnancy or breastfeeding, in neuromuscular conditions such as myasthenia gravis, where there is infection at the treatment site, or in cases of known allergy. With hyaluronic acid fillers, longevity varies by area and product, with a general range of 6 to 18 months. Bruising and swelling are common and settle within days to two weeks; nodules, product migration and delayed inflammatory reaction require medical follow-up. Vascular occlusion, a rare but serious complication, can lead to skin necrosis and very rarely to loss of vision around the eye and nose; it requires an emergency hyaluronidase protocol, and for that reason filler should be carried out only in a clinical setting by physicians able to manage it. Fillers are not advised during pregnancy or breastfeeding and are not carried out, or are postponed, where there is active infection, an active cold sore or a known allergy.
Content overseen by Aysun Kaya, Founder · Kaya Clinique · on Bağdat Avenue since 2019. Our publishing standards are set out in our editorial principles.
